Etu esi eji Metglib?

Biko tupu ịzụta mbadamba Metglib kpuchitere na ndọrọ n'agha. 2,5 mg + 400 mg, pcs 40,, lelee ozi gbasara ya yana ozi dị na weebụsaịtị webụsaịtị nke ndị na - emepụta ma ọ bụ kọwaa nkọwapụta nke ụdị akọwapụtara ya na onye njikwa ụlọ ọrụ anyị!

Ihe omuma egosiputara na saịtị a abughi ihe enyere ndi mmadu aka. Onye rụpụtara ya nwere ikike ịme mgbanwe n ’okike, imewe na ịkwakọ ngwaahịa. Foto nke ngwongwo na foto nke egosiri na katalọgụ saịtị ahụ nwere ike ịdị iche na mbido mbụ.

Ozi banyere ọnụahịa nke egosiri na katalọgụ saịtị ahụ nwere ike ịdị iche na nke ahụ n'ezie n'oge etinyebere iwu maka ngwaahịa kwekọrọ.

Emeputa

Otu mbadamba 1 nwere:

bekee na-arụ ọrụ: metformin hydrochloride 400 mg, glibenclamide 2.5 mg,

ndị na-achịkwa: kalịnda hydrogen phosphate dihydrate 50 mg, ọka ọka 45 mg, croscarmellose sodium 12 mg, sodium stearyl fumarate 3 mg, povidone 52 mg, microcrystalline cellulose 35.5 mg, uwe ihe nkiri: Opadry oroma 20 mg, gụnyere: hypromellose (hydroxypropyl m celyl celyl) ) 6.75 mg, hyprolose (hydroxypropyl cellulose) 6.75 mg, talc 4 mg, titanium dioxide 2.236 mg, sọks iron oxide red 0.044 mg, iron oxide odo oxide 0.22 mg.

Omume ọgwụ

Nchikota nke onodu onu aru nke onu abuo nke ndi otu ogwu: metformin na glibenclamide. Metformin bụ otu nke biguanides ma belata ọdịnaya nke basal na postprandial glucose n'ọbara plasma. Metformin adịghị akpali insulin insulin, ya mere anaghị akpata hypoglycemia.

O nwere usoro ihe omume 4:

- na - ebelata mmepụta nke glucose site na umeji site na igbochi gluconeogenesis na glycogenolysis,

- na-abawanye uche nke ndị na - anabata ihe na - eme insulin, ike na ojiji nke glucose site na mkpụrụ ndụ na akwara.

- na-egbu oge ịmịnye glucose na eriri afọ,

- na - eme ka ahu ike ma obu iwetulata ahu ike n’ebe ndi oria oria aria mellitus di.

Diabetesdị shuga 2 n'ime ndị okenye:

- na adighi ike nke usoro ọgwụgwọ nri, mmega ahụ na monotherapy gara aga na usoro metformin ma ọ bụ usoro sulfonylurea,

- iji dochie ọgwụ abụọ gara aga jiri ọgwụ abụọ (metformin na usoro sulfonylurea) na ndị ọrịa nwere ọkwa glycemia kwụ chịm ma chịkwaa nke ọma.

Ihe ngbanwe

- Hypersensitivity na metformin, glibenclamide ma ọ bụ ihe ndị ọzọ na - eme ka sulfonylurea, yana akụkụ ndị ọzọ nke nkwadebe Metglib,

- ụdị shuga 1

- mamịrị ketoacidosis, ọrịa mamịrị, ụkwara ume ọkụ,

- ọdịda akụrụngwa ma ọ bụ ọrụ akụrụngwa arụrụala (mwepu nke na-erughi 60 ml / min),

- ọnọdụ ọjọọ nke nwere ike ibute mgbanwe na ọrụ akụrụ: akpịrị ịkpọ nkụ, ọrịa na-efe efe, ujo, nchịkwa intravaskụla nke ndị ọrụ iodinated dị iche iche,

- ọrịa ukwu ma ọ bụ nke na-adịghị ala ala nke hypoxia anụ ahụ na-eso: obi ma ọ bụ akụkụ okuku ume na-arịa, na-adịbeghị anya infarction myocardial,

afọ ime, oge ị ofụ ara,

- nhazi nke miconazole,

- ọrịa na-efe efe, nnukwu ịwa ahụ, mmerụ ahụ, oke ọkụ na ọnọdụ ndị ọzọ chọrọ ọgwụgwọ insulin,

- egbu egbu egbu, ị alcoholụbiga mmanya ókè

- lactic acidosis (gụnyere akụkọ ihe mere eme),

- gbaso nri di kalori (ihe kariri 1000 kcal / day),

- afọ ụmụaka rue afọ 18.

A naghị atụ aro ka iji ọgwụ ahụ mee ihe na ndị mmadụ karịa afọ 60 bụ ndị na-arụ ọrụ anụ ahụ dị arọ, nke ejikọtara ya na oke ihe ize ndụ nke ịmalite ọrịa lactic acidosis n'ime ha.

- hypofunction nke isi nsogbu,

- ọrịa nke thyroid gland (na uncompensated imebi ọrụ ya),

- n'ime ndị agadi karịrị afọ 70 n'ihi oke ọnya hypoglycemia.

Nsonaazụ

Nsonaazụ ndị a na-esote nwere ike ịme n'oge ọgwụgwọ na Metglib®. Nhazi nke WHO banyere ihe ndị ọ ga-akpata:

oge ọ bụla - ≥1 / 10 ọkwa (> 10%)

ọtụtụ mgbe site na ≥1 / 100 ruo 1% na

ugboro ugboro - site ≥1 / 1000 ruo 0.1% na

adịkarịghị - si ≥1 / 10000 to0.01% na

Nkewa nke mmeghachi omume na-adịghị mma dabere na mmebi akụkụ ahụ yana sistemụ akwara (akwụkwọ ọkọwa okwu ahụike nke ihe omume Med-DRA).

- Nmebi nke ọbara na sistem lymphatic:

Ihe omume ndị a na-apụ n'anya mgbe ịkwụsị ọgwụ.

Ikebịghike: leukopenia na thrombocytopenia.

O siri ike: agranulocytosis, anaemia hemolytic, ụkwara ọkpụkpụ, na pancytopenia.

- Nsogbu usoro immune:

O siri ike: ujo anafilactic.

Mmeghachi omume mmadụ na-eme ka mmadụ nwegasịrị mmetụta na sulfonamides na usoro ha nwere ike ime.

- Ọrịa site na metabolism na nri nri: Hypoglycemia.

Ọ na-adịkarị: mkpụkọ nke hepatic porphyria na cutaneous porphyria.

O siri ike: lactic acidosis.

Mbelata vitamin nke B12 belata, tinyere mbelata nke itinye uche ya na ọbara a na-eji ọgwụ ogologo oge. Ọ bụrụ na achọpụtara ọbara ọgbụgba megaloblastic, enwere ike ịtụle ohere etiology dị otú a. Disulfiram dị ka mmeghachi omume ethanol.

- Mmebi nke ụjọ usoro:

Otutu: uto nsogbu (uto “otite”) n’onu.

Ọrịa nlegharị anya: na mbido ọgwụgwọ, imerụ anya nwa oge nwere ike ime n'ihi mbelata glucose ọbara.

- Ọrịa nke eriri afọ:

Ọtụtụ mgbe: ọgbụgbọ, ọgbụgbọ, afọ ọsịsa, ọnya afọ na enweghị agụụ. Mgbaàmà ndị a bụ ihe a na-ahụkarị na mbido ọgwụgwọ ma n'ọtụtụ ọnọdụ na-ebugharị na nke ha. Iji gbochie mmepe nke mgbaàmà ndị a, a na-atụ aro ka ị theụ ọgwụ ahụ n'ime ọgwụ abụọ ma ọ bụ atọ, mmụba ngwa ngwa nke ọgwụ ahụ na-eme ka ọ nwekwuo ndidi.

- Ọrịa site na imeju na ọnya biliary:

Ọ dịkarịghị ala: ihe ngosipụta ọrụ imeju na - arụ ọrụ ma ọ bụ ịba ọcha n'anya nke chọrọ ọgwụgwọ.

Ọkpụkpụ sitere na anụ ahụ yana anụ ahụ dị n'okpuru ala:

N'oge na-adịghị anya: mmeghachi omume anụ ahụ, dịka: pruritus, urticaria, maculopapular fash.

Ahụkarị ọsịsọ: anụ ahụ ma ọ bụ visasicallar vasculitis, polymorphic erythema, exfoliative dermatitis, photoensitivity.

- Laboratory na ngwá data:

N’oge na-adịghị anya: mmụba na mkpokọta urea na creatinine n’ime ọbara site na obere ruo n’iru.

Ọ dị ụkọ: hyponatremia.

Mmekorita

Njikọ na Ojiji nke Glibenclamide

Miconazole nwere ike ịkpalite mmepe nke hypoglycemia (ruo mmepe nke coma).

Metformin metụtara

Iodine nwere ihe dị iche na-arụ ọrụ: ọ dabere na ọrụ akụrụ, ekwesịrị ịkwụsị ọgwụ a awa 48 tupu ma ọ bụ mgbe nchịkwa introvenous nke ndị na-enwe iodine nwere.

Njikọ ndị a tụrụ aro: jikọtara ya na ojiji nke usoro sulfonylurea

Ethanol: a na-ahụkarị mmeghachi omume disulfiram (ethanol ntachi obi) mgbe ọ na-ewere ethanol na glibenclamide. Ethanol nwere ike iwelie mmetụta hypoglycemic (site na igbochi mmeghachi ahụ na-akwụghachi ụgwọ ma ọ bụ na-egbu oge na-egbochi metabolic), nke nwere ike itinye aka na mmepe nke hypoglycemic coma. N'oge ọgwụgwọ nke Metglib®, a ga-ezere mmanya na ọgwụ ndị nwere ethanol. Phenylbutazone na-abawanye ike hypoglycemic mmetụta nke ihe dị n'ụkpụrụ sulfonylurea (na-edochi ihe ntụpọ sulfonylurea na saịtị protein na / ma ọ bụ belata ntụpọ ha). Ọ ka mma iji ọgwụ mgbochi ọgwụ ndị ọzọ na-egosi enweghị mmekorita, ma ọ bụ dọọ onye ọrịa aka ná ntị banyere mkpa ọ bụla iji chịkwaa ọkwa nke glycemia, ọ bụrụ na ọ dị mkpa, ekwesịrị ịhazigharị ọgwụ ahụ mgbe ejiri ọgwụ mgbochi mgbochi ọnụ jikọtara ọnụ na mgbe ịkwụsị ya.

Njikọ na Ojiji nke Glibenclamide

Bozentan na glibenclamide na-abawanye ohere nke hepatotoxicity.

A na-atụ aro ka ị zere ị theseụ ọgwụ ndị a n'otu oge. Mmetụta hypoglycemic nke glibenclamide nwekwara ike ibelata.

Metformin metụtara

Ethanol: ihe egwu nke ịbawanye lactic acidosis na-abawanye site na nnukwu ị ,ụ mmanya na-egbu egbu, karịsịa n'ihe banyere agụụ, ma ọ bụ nri na-edozi ahụ, ma ọ bụ ọdịda imeju. N'oge ọgwụgwọ nke Metglib®, a ga-ezere mmanya na ọgwụ ndị nwere ethanol.

Etu ị ga-esi, usoro nchịkwa na usoro onunu ogwu

Ọ bụ dibia na-agakọ, ka ihe niile gbasara usoro ọgwụ ahụ, na oge ọgwụgwọ a ka ọ dị n’aka ndị ọka iwu na - elegharị anya na steeti ahụ, dabere na mkpokọta glucose na plasma ọbara. Dịka iwu, usoro izizi bụ mbadamba 1-2 kwa ụbọchị na nri isi, yana ịhọrọ nwayọ nwayọ nwayọ rue mgbe a ga-enweta ọkwa zuru oke nke glucose na plasma ọbara. Ogo kachasị Metglib® kwa ụbọchị bụ mbadamba 6, nke kewara ụzọ atọ.

Dodoụbiga ya ókè

N'ihe banyere ịdoụbiga mmanya ókè, hypoglycemia nwere ike ịmalite n'ihi ọnụnọ nke usoro ọgwụ sulfonylurea na nkwadebe.

Enwere ike idozi ntakịrị ihe mgbaàmà hypoglycemia na-enweghị ume na ngosipụta akwara ozi site na ị immediateụ shuga ozugbo. Ọ dị mkpa iji megharia dose na / ma ọ bụ gbanwee nri. Ọnọdụ mmeghachi omume hypoglycemic siri ike na ndị ọrịa nwere ọrịa shuga, yana coma, paroxysm, ma ọ bụ nsogbu ndị ọzọ metụtara akwara, chọrọ nlekọta ahụike mberede. Nlekọta intravense nke usoro dextrose dị mkpa ozugbo achọpụtara ma ọ bụ enyo enyo nke hypoglycemia, tupu ụlọ ọgwụ onye ọrịa. Mgbe ọ nwetasịrị, ọ dị mkpa inye onye ọrịa ahụ nri nwere nnukwu carbohydrates na-adị ngwa ngwa (iji zere ịmalite ịmalite hypoglycemia).

Mkpochasị Plasma glibenclamide nwere ike ịbawanye na ndị ọrịa nwere ọrịa imeju. Ebe ọ bụ na glibenclamide nwere njikọ chiri anya na protein ndị dị n'ọbara, a naghị ewepụ ọgwụ ahụ n'oge a na-ahụ ya.

Do overụbiga mmanya ókè ma ọ bụ ọnụnọ nke ihe ndị dị ize ndụ nwere ike ịkpasu mmepe nke lactic acidosis, ebe ọ bụ na metformin bụ akụkụ nke ọgwụ ahụ.

Lactic acidosis bụ ọnọdụ chọrọ nlekọta ahụike mberede, ọgwụgwọ nke lactic acidosis kwesịrị ịrụ n'ụlọ ọgwụ. Treatmentzọ ọgwụgwọ kachasị dị irè maka iwepu lactate na metformin bụ hemodialysis.

International Nonproprietary Aha

Glibenclamide + Metformin (Glibenclamide + Metformin)

A gụnyere ọgwụ a n’otu ọgwụ na-edozi glucose ọbara.

A10BD02. Metformin na njikọ sulfonamides

Weputara udi ya na ihe mebere ya

Ọgwụ dị n'ụdị mbadamba nkume. Dị ka ihe ndị bụ isi ji arụ ọrụ, a na-eji metformin hydrochloride na glibenclamide. Ntinye uche ha na mbadamba 1: 400 mg na 2.5 mg. Ihe ndi ozo adighi egosiputa aru oru hypoglycemic:

• calcium hydrogen phosphate akpọnwụwo,
• ọka ọka
• sodium croscarmellose
• sodium stearyl fumarate,
• povidone
• microcrystalline cellulose.

Ngwaahịa a dị na ngwugwu ekwentị 40 PC.

Ọgwụ dị n'ụdị mbadamba nkume.

Mlọ ọgwụ

Ntinye glibenclamide mgbe ọ banyere n’ime akwara nri bụ 95%. Ruo awa anọ, a na-enweta ihe ngosipụta kachasị elu nke ihe ahụ. Uru nke onyinye a bụ ihe fọrọ nke nta ka ọ bụrụ ihe nchebe dị na protein ndị dị na plasma (ihe ruru 99%). Akụkụ dị mkpa nke glibenclamide ka a na-agbanwegharị na imeju, n'ihi nke etolite metabolites 2, nke na-egosighi ọrụ ma na-ewepu ya na eriri afọ ya na akụrụ. Usoro a na - ewe oge nke 4 ruo 11 awa, nke steeti ahụ na-ekpebisi ike, usoro nke ihe ahụ na - arụ ọrụ, ọnụnọ nke ọrịa ndị ọzọ.

A na-etinye Metformin obere ntakịrị, bioav adị ya adịghị agafe 60%. Akụ a na-ebute oke ọrụ ya ngwa ngwa karịa glibenclamide Ya mere, arụmọrụ kachasị elu nke metformin bụ ihe mkpuchi elekere 2.5 mgbe ị theụsịrị ọgwụ.

Ngwakọta a nwere ndọghachi azụ - mbelata nke ukwuu na ọsọ ọsọ mgbe ị na-eri nri. Metformin enweghị ike ịrapara n'ahụ protein dị n'ọbara. Ihe ahu agbanweghi agbanwe, dika ike na-aga ịgbanwe. Akụrụ na-ahụ maka ọpụpụ ya.

Metformin enweghị ike ịrapara n'ahụ protein dị n'ọbara.

Ihe ngosi maka ojiji

Ebumnuche bụ ebumnuche bụ ime ka ọrịa dị n'ọrịa shuga dị afọ 2.

A na-arụ ọrụ ndị a:

• nnọchi usoro ọgwụgwọ gara aga na ndị ọrịa nwere ọkwa glucose na-achịkwa.
• na-enye nsonaazụ megide mmalite nke ịdị ala ọgwụgwọ ọrịa, mmega ahụ na ọgwụgwọ nke ndị ọrịa oke ibu.

Jiri nlezianya

Ọtụtụ ihe ndị a na - egbochi ọgwụ iji gbochie ọgwụ:

• ahụ ọkụ
• mbelata nke olu ihe ọgbụgba.
• ọnya ọnya ọnya na-esite na ngụkọta akpakọrịta nke gland thyroid,
• adrenal ezughi oke.

Na-arịa ọrịa shuga

Ntụziaka maka iji Metglib:

• na mmalite nke ọgwụgwọ, a na-atụ aro ka ị were mbadamba 1-2 kwa ụbọchị,
• na-esote, usoro ubochi na-agbanwe, nke dabere na ọkwa glucose dị n'ọbara, ọ dịkwa mkpa iji nweta nsonaazụ na-adịgide adịgide.

n'oge mmalite ọgwụgwọ, a na-atụ aro ka ị were mbadamba 1-2 kwa ụbọchị.

Oke ọgwụ a na-anabata ka ụbọchị ọ bụla maka ọrịa shuga 2 bụ mbadamba 6. Ma inwere ike iwere ha n’otu oge. O di nkpa iji kee uzo ekwuputara n’ime uzo ato kwesiri ya.

Maka ịdị felata

Achọpụtala na iji ihe (metformin na glibenclamide), nke bụ akụkụ nke Metglib, na - enye aka belata abụba. Usoro akwadoro kwa ụbọchị bụ mbadamba 3. Anakwere na etiti oge. Usoro ọgwụgwọ bụ ụbọchị 20. Iji gbochie ọdịdị nke oke ibu, a na-ebelata dose ahụ ka 200 mg otu ugboro, ego kwa ụbọchị bụ 600 mg.

Ọgwụ anaghị enye nsonaazụ achọrọ n'enyereghị aka. Ihe ndị dị na ya mejupụtara na-enyere aka igbochi ntụgharị nke ike abụba ahụ.

Iji zere mmụba nke oke abụba, achọrọ ya iwelie anụ ahụ ike ma mezie nri na ojiji nke ọgwụ.

Jiri n'oge ime na lactation

Amachibidoro ọgwụ a maka iji emee ya na oge ị na-enye nwa ara. Ihe ndị nọ n'ọrụ na-abanye na mmiri ara nne. Ọ bụrụ na ọ dị mkpa ngwa ngwa iji ọgwụ a n'oge a na-enye nwa na atụmatụ ime, a na-eme usoro ọgwụgwọ insulin.

Amachibidoro ọgwụ a maka iji emee ya na oge ị na-enye nwa ara.

Onye ka edere ọgwụ ahu

Ọnụ nke Metglib bụ ụdị ọrịa shuga 2 naanị. Ọzọkwa, a na-enye ọgwụ ahụ ọ bụghị na mmalite ọrịa ahụ, kama ọ na-enwe ọganihu. Na mmalite nke ọrịa shuga, ihe ka ọtụtụ n'ime ndị ọrịa ekwupụtala na ha na-eguzogide insulin, ọ dịghịkwa mgbanwe na-enweghị isi na njikọ insulin. Ọgwụ zuru oke na ọkwa a bụ nri nwere obere carb, mmega ahụ aerobic, na metformin. A chọrọ Metglib mgbe ụkọ insulin kpatara.Na nkezi, nsogbu a na-apụta na afọ 5 mgbe mmụba mbụ nke shuga dị.

Enwere ike ịnye ọgwụ Metglib abụọ mejupụtara:

• ọ bụrụ na usoro ọgwụgwọ gara aga anaghị enye ma ọ bụ ogologo oge akwụsịla ịkwụ ụgwọ maka ọrịa shuga.
• ozugbo achọpụtara ọrịa shuga 2dị nke Abụọ, ọ bụrụ na onye ọrịa nwere oke shuga zuru oke (> 11). Mgbe usoro iwu nke ịdị arọ na mbelata insulin na-eguzogide ọgwụ, enwere ike nke ukwuu na usoro nke Metglib ga-atụgharị belata ma ọ bụ ọbụna ga-aga naanị na Metformin,
• ọ bụrụ na ule maka C-peptide ma ọ bụ insulin dị ala karịa, n’agbanyeghi ogologo ọrịa shuga,
• maka ịdị mfe nke iji ya, ndị ọrịa mamịrị na-a drugsụ ọgwụ abụọ, glibenclamide na metformin. Inweta Metglib na-enye gị ohere ịbelata ọnụ ọgụgụ mbadamba. Dabere na ndị ọrịa mamịrị, nke a na-ebelata oke ihe ize ndụ nke ichefu ị takeụ ọgwụ.

Uzo esi aga Metglib

Metglib na-a drinkụ otu oge nri. Ọgwụ nwere ihe ụfọdụ pụrụ iche maka ihe mejupụtara nke ngwaahịa a. Na ọrịa shuga mellitus, carbohydrates kwesịrị ịdị na nri ọ bụla, akụkụ kachasị ha kwesịrị ịnwe ndepụta glycemic dị ala.

Site na mmụba na ọnụọgụ mbadamba, ha na-ekewa abụọ (n'ụtụtụ, na mgbede), wee banye na 3 usoro.

Ndepụta nke mmetụta dị n'akụkụ

Ndepụta nke nsonaazụ na-adịghị mma nke nwere ike ibute site na iwere Metglib:

Dọkịta nke Sciences Medical, Isi nke Institute of Diabetology - Tatyana Yakovleva

M na-amụ ọrịa shuga kemgbe ọtụtụ afọ. Ọ na-atụ ụjọ mgbe ọtụtụ mmadụ nwụrụ, nweekwa nkwarụ karịa n'ihi ọrịa shuga.

Emere m ngwa ngwa izisa ozi ọma - Endocrinological Research Center nke Russian Academy of Medical Sciences jisiri ike mepụta ọgwụ na-agwọ ọrịa shuga kpamkpam. N'oge a, ịdị irè nke ọgwụ a na-eru nso 98%.

Ozi ọma ọzọ: Ministri Ahụike echekwaala maka mmemme pụrụ iche nke na-akwụ ụgwọ ọgwụ dị elu. Na Russia, ndị ọrịa mamịrị ruo Mee Mee 18 (isonye) nwere ike inweta ya - Naanị 147 rubles!

A na-akpọkarịkarị mmetụta Metglib hypoglycemia. Ọrịa ya dabere na omume onye ọrịa nwere ọrịa shuga, yabụ ihe egwu ya agaghị ekwe omume ịgbakọ. Iji gbochie mmiri shuga, ị kwesịrị ịdị na-eri carbohydrates n'otu ụbọchị, emela nri, kwụọ ụgwọ maka nri ogologo oge nke carbohydrate, ị nwere ike ịchọ nri ozugbo n'oge klaasị. Ọ bụrụ na usoro ndị a enyereghị aka, ọ ka mma ịji ọgwụ ogwu dị nro dochie Metglib.

Jiri na agadi

Ekwesịrị izere iji Metglib ma ọ bụrụ na onye ọrịa ahụ na-arụ ọrụ dị ike. N'okwu a, enwere ihe ize ndụ nke lactic acidosis. Ihe mgbochi dị otú a na-emetụta ndị ọrịa gafere afọ 60. Na mgbakwunye, ekwesịrị ịkpachara anya na ọgwụgwọ nke ndị ọrịa agadi site na afọ 70 ma ọ bụ karịa. Nke a nwere ike iduga mmepe nke hypoglycemia.

Jiri maka ọrụ imeju na-arụ ọrụ

Amachibidoro ọgwụ a maka iji ya mee ihe maka arụ ọrụ nke aru a. Buru n’uche n’uche nke creatinine (ikpebi ihe ngosipụta a n’ime ụmụ nwoke bụ 135 mmol / l, n’ime ụmụ nwanyị - 110 mmol / l).

Amachibidoro ọgwụ a maka iji ya mee ihe na enweghi ike imeju.

Mmanya ndakọrịta

Ọgwụ a na-a questionụ na-eme ka ọdịdị nke mmeghachi omume na-adịghị mma n'okpuru mmetụta nke ethanol dị na mmanya na-aba n'anya. Ọzọkwa, enwere mmụba na arụ ọrụ nke Metglib megide mmalite nke ị againstụ mmanya, nke nwere ike ibute nsogbu.

Nkọrịta ọnụ bara uru nwere otu ihe mejupụtara:

• Gluconorm,
• Glibomet,
• Glucovans, mana na nke a, usoro ọgwụgwọ nke metformin dị elu - 500 mg,
• Metglib Force (ọnụọgụ nke metformin - 500 mg).

Ana eme ogwu gluconorm.
Ihe analog nke ogwu bu Glibomet.
Glucovans ọgwụ analogue.
analogue nke ọgwụ Metglib Force.